Giannico R, Oliveira C A, Solé D, Naspitz C K
Department of Pediatrics, Federal University of São Paulo, Escola Paulista de Medicina, Brazil.
J Investig Allergol Clin Immunol. 1996 Mar-Apr;6(2):110-6.
Twenty-three children with chronic allergic rhinitis (Group A) and eleven normal non-atopic subjects (group C) were submitted to non-specific nasal provocation tests with histamine (0.03; 0.06; 0.125; 0.25; 0.5; 1.0; 2.0 and 4.0 mg/ml), and one week later with methacholine (0.025; 0.1; 0.25, 0.5; 1.0; 2.5; 5.0 and 10.0 mg/ml). Measurements of total nasal resistance were performed by active anterior rhinomanometry (Berger, S.A.) and symptoms were recorded. Challenges were carried out in the morning with all children in an acclimatized room (25 degrees C/77 degrees F). Concentrations of the tested drugs were increasingly instilled, and after 5 min were followed by total nasal resistance, FEV, and FVC measurements. Considering as positive those tests in which total nasal resistance had a 100% increase, we observed that both histamine and methacholine caused an increase in total nasal resistance as instilled drug concentration rose; histamine provocations were significantly more positive among group A than group C patients (91% sensitivity, 80.8% positive predictive value). This was not observed with methacholine (55% sensitivity, 75% positive predictive value). In neither provocation was there correlation between the concentration that induced a positive response and symptoms. There were no changes in spirometric values during the tests. Nasal provocations with histamine and methacholine are safe and well tolerated. Histamine seems to be more adequate for differentiating children with allergic rhinitis from normal controls.
23名患有慢性变应性鼻炎的儿童(A组)和11名正常非特应性受试者(C组)接受了组胺(0.03;0.06;0.125;0.25;0.5;1.0;2.0和4.0mg/ml)的非特异性鼻激发试验,一周后接受了乙酰甲胆碱(0.025;0.1;0.25;0.5;1.0;2.5;5.0和10.0mg/ml)的非特异性鼻激发试验。通过主动前鼻测压法(伯杰,S.A.)测量总鼻阻力,并记录症状。所有儿童均于上午在温度适宜的房间(25摄氏度/77华氏度)内进行激发试验。逐渐滴入受试药物的浓度,5分钟后测量总鼻阻力、第一秒用力呼气容积(FEV)和用力肺活量(FVC)。将总鼻阻力增加100%的试验视为阳性,我们观察到随着滴入药物浓度的升高,组胺和乙酰甲胆碱均导致总鼻阻力增加;A组患者中组胺激发试验的阳性率显著高于C组患者(敏感性91%,阳性预测值80.8%)。乙酰甲胆碱激发试验未观察到这种情况(敏感性55%,阳性预测值75%)。在两种激发试验中,引起阳性反应的浓度与症状之间均无相关性。试验期间肺功能测定值无变化。组胺和乙酰甲胆碱鼻激发试验安全且耐受性良好。组胺似乎更适合于区分变应性鼻炎儿童与正常对照。